In-vitro Colorectal Cancer Screening Tests Market by End-user and Geography - Forecast and Analysis 2021-2025

The in-vitro colorectal cancer screening tests market size has the potential to grow by USD 270.96 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 5.60%. 

This report provides a detailed analysis of the market by end-user (hospitals, clinical diagnostic laboratories, and others), geography (North America, Europe, Asia, and ROW), and key vendors. 

Market Overview

Browse TOC and LoE with selected illustrations and example pages of In-vitro Colorectal Cancer Screening Tests Market

 Request a FREE sample now!

Market Competitive Analysis

The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

• Abbott Laboratories
• Danaher Corp.
• Epigenomics AG
• Exact Sciences Corp.
• Immunostics Inc.
• NOVIGENIX SA
• QIAGEN NV
• Quest Diagnostics Inc.
• R-Biopharm AG
• Sysmex Corp.

 

The in-vitro colorectal cancer screening tests market is fragmented and the vendors are deploying growth strategies such as R&D to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

The market players also significantly leverage external market drivers such as the rising occurrence of colorectal cancer to achieve growth opportunities. However, factors such as lack of manpower will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the in-vitro colorectal cancer screening tests market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

This in-vitro colorectal cancer screening tests market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. 

In-vitro Colorectal Cancer Screening Tests Market: Key Drivers and Trend

Factors such as a growing obese population, unhealthy diet, lack of physical activity, and increasing number of smokers increase the risk of developing colorectal cancer. The rising number of cases of colorectal cancer increased awareness about the required screening process in the world, which involves the increase in the use of in-vitro colorectal cancer screening tests. The rising number of colorectal cancer deaths indicates the need for in-vitro colorectal cancer screening tests, which contributes to the growth of the market.

The growing awareness programs and government initiatives is a significant factor driving the growth of the market during the forecast period. Knowledge and awareness about colorectal cancer screening is an essential aspect for people.  Therefore, compulsory education and economic development are major solutions to raise awareness about the disease.  Also, government initiatives such as Colorectal Cancer Control Program and insurance policies like Medicaid and Medicare are working toward providing colorectal cancer screening tests to many patients in the US. Therefore, numerous government initiatives and public programs can result in the increased adoption of in-vitro colorectal cancer screening tests, which will positively impact the growth of the market.

 

Grab your Free Sample now to unlock further information on other key market drivers

In-vitro Colorectal Cancer Screening Tests Market: Segmentation by Geography

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market’s growth will originate from North America during the forecast period. The US is a key market for in-vitro colorectal cancer screening tests in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.

The significant investments in healthcare research and testing will facilitate the in-vitro colorectal cancer screening tests market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report. 

In-vitro Colorectal Cancer Screening Tests Market: Segmentation by End-user

Request for a FREE sample and Get more information on the market contribution of various segments

Hospitals have the advanced medical infrastructure to cater to the needs of people. Hospitals are increasingly focusing on screening, monitoring, and diagnosis of colorectal cancer as an outpatient procedure. Most importantly, hospital settings provide opportunities for patients who do not have access to facilities such as clinical diagnostic laboratories. Globally, most hospitals have tie-ups with R&D centers and research institutes, which can increase the development and efficiency of screening tests in the market.

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the in-vitro colorectal cancer screening tests market size.

 

Request for a FREE sample

In-vitro Colorectal Cancer Screening Tests Market: Key Highlights of the Report for 2021-2025

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive in-vitro colorectal cancer screening tests market growth during the next five years
• Precise estimation of the in-vitro colorectal cancer screening tests market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the in-vitro colorectal cancer screening tests industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of in-vitro colorectal cancer screening tests market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

In-vitro Colorectal Cancer Screening Tests Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 6%
Market growth 2021-2025	$ 270.96 million
Market structure	Fragmented
YoY growth (%)	5.19
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 39%
Key consumer countries	US, Germany, Japan, UK, and France
Competitive landscape	Leading companies, competitive strategies, consumer engagement scope
Companies profiled	Abbott Laboratories, Danaher Corp., Epigenomics AG, Exact Sciences Corp., Immunostics Inc., NOVIGENIX SA, QIAGEN NV, Quest Diagnostics Inc., R-Biopharm AG, and Sysmex Corp.
Market Dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.